From the Departments of Neurology (E.Y.U., T.R.T., M.R., S.R.N., J.B., S.W.A.), Internal Medicine (K.C.D., J.N.K.), Radiology (V.M.), Biostatistics (J.D.D., D.R.B.), Psychology (M.W.V.), and Health and Human Physiology (W.G.D.), University of Iowa, Iowa City; Neurology Service (E.Y.U., T.R.T., S.R.N.), Veterans Affairs Medical Center, Iowa City, IA; Department of Neurology (S.M., T.J.G.), University of Washington, Seattle; and Department of Psychology (A.F.K.), Beckman Institute, University of Illinois, Urbana-Champaign.
Neurology. 2014 Jul 29;83(5):413-25. doi: 10.1212/WNL.0000000000000644. Epub 2014 Jul 2.
To (1) investigate effects of aerobic walking on motor function, cognition, and quality of life in Parkinson disease (PD), and (2) compare safety, tolerability, and fitness benefits of different forms of exercise intervention: continuous/moderate intensity vs interval/alternating between low and vigorous intensity, and individual/neighborhood vs group/facility setting.
Initial design was a 6-month, 2 × 2 randomized trial of different exercise regimens in independently ambulatory patients with PD. All arms were required to exercise 3 times per week, 45 minutes per session.
Randomization to group/facility setting was not feasible because of logistical factors. Over the first 2 years, we randomized 43 participants to continuous or interval training. Because preliminary analyses suggested higher musculoskeletal adverse events in the interval group and lack of difference between training methods in improving fitness, the next 17 participants were allocated only to continuous training. Eighty-one percent of 60 participants completed the study with a mean attendance of 83.3% (95% confidence interval: 77.5%-89.0%), exercising at 46.8% (44.0%-49.7%) of their heart rate reserve. There were no serious adverse events. Across all completers, we observed improvements in maximum oxygen consumption, gait speed, Unified Parkinson's Disease Rating Scale sections I and III scores (particularly axial functions and rigidity), fatigue, depression, quality of life (e.g., psychological outlook), and flanker task scores (p < 0.05 to p < 0.001). Increase in maximum oxygen consumption correlated with improvements on the flanker task and quality of life (p < 0.05).
Our preliminary study suggests that aerobic walking in a community setting is safe, well tolerated, and improves aerobic fitness, motor function, fatigue, mood, executive control, and quality of life in mild to moderate PD.
This study provides Class IV evidence that in patients with PD, an aerobic exercise program improves aerobic fitness, motor function, fatigue, mood, and cognition.
(1)研究有氧步行对帕金森病(PD)患者运动功能、认知和生活质量的影响,(2)比较不同运动干预形式的安全性、耐受性和健身益处:连续/中等强度与间歇/交替低强度和高强度,以及个体/社区与小组/机构设置。
最初的设计是一项为期 6 个月的、2×2 随机试验,比较了不同运动方案对独立行走的 PD 患者的影响。所有组都需要每周运动 3 次,每次 45 分钟。
由于后勤因素,分组/机构设置的随机化不可行。在头两年,我们将 43 名参与者随机分为连续训练或间歇训练组。由于初步分析表明间歇组的肌肉骨骼不良事件较高,而且两种训练方法在提高适应性方面没有差异,因此接下来的 17 名参与者仅被分配到连续训练组。60 名参与者中的 81%完成了研究,平均出勤率为 83.3%(95%置信区间:77.5%-89.0%),心率储备的 46.8%(44.0%-49.7%)。没有严重的不良事件。在所有完成者中,我们观察到最大摄氧量、步态速度、统一帕金森病评定量表(UPDRS)I 和 III 评分(特别是轴功能和僵硬)、疲劳、抑郁、生活质量(如心理展望)和侧抑制任务评分的改善(p<0.05 至 p<0.001)。最大摄氧量的增加与侧抑制任务和生活质量的改善相关(p<0.05)。
我们的初步研究表明,在社区环境中进行有氧运动是安全的、耐受良好的,可以提高轻度至中度 PD 患者的有氧适能、运动功能、疲劳、情绪、执行控制和生活质量。
这项研究提供了 IV 级证据,表明在 PD 患者中,有氧运动方案可以改善有氧适能、运动功能、疲劳、情绪和认知。